Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP413677.RA2Sud5L0K129j4kjqN4i4lC6JCDHniPdjF1BcQPyb-FE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP413677.RA2Sud5L0K129j4kjqN4i4lC6JCDHniPdjF1BcQPyb-FE130_assertion type Assertion NP413677.RA2Sud5L0K129j4kjqN4i4lC6JCDHniPdjF1BcQPyb-FE130_head.
- NP413677.RA2Sud5L0K129j4kjqN4i4lC6JCDHniPdjF1BcQPyb-FE130_assertion wasGeneratedBy ECO_0000203 NP413677.RA2Sud5L0K129j4kjqN4i4lC6JCDHniPdjF1BcQPyb-FE130_provenance.
- NP413677.RA2Sud5L0K129j4kjqN4i4lC6JCDHniPdjF1BcQPyb-FE130_assertion wasDerivedFrom befree-20140225 NP413677.RA2Sud5L0K129j4kjqN4i4lC6JCDHniPdjF1BcQPyb-FE130_provenance.
- NP413677.RA2Sud5L0K129j4kjqN4i4lC6JCDHniPdjF1BcQPyb-FE130_assertion SIO_000772 8614004 NP413677.RA2Sud5L0K129j4kjqN4i4lC6JCDHniPdjF1BcQPyb-FE130_provenance.
- NP413677.RA2Sud5L0K129j4kjqN4i4lC6JCDHniPdjF1BcQPyb-FE130_assertion evidence source_evidence_literature NP413677.RA2Sud5L0K129j4kjqN4i4lC6JCDHniPdjF1BcQPyb-FE130_provenance.
- NP413677.RA2Sud5L0K129j4kjqN4i4lC6JCDHniPdjF1BcQPyb-FE130_assertion description "[We measured expression levels of three different reductase enzymes-DT-diaphorase [NAD(P)H (i.e., reduced nicotinamide adenine dinucleotide, with or without phosphate): quinone oxidoreductase]; NADPH:cytochrome P-450 reductase; and NADH (i.e., reduced nicotinamide adenine dinucleotide): cytochrome-b5 reductase- in 69 cell lines (most of the National Cancer Institute [NCI] human tumor cell panel) to see if relationships could be established between the activities of these enzymes and cellular sensitivities to the bioreductive compounds mitomycin C and EO9.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP413677.RA2Sud5L0K129j4kjqN4i4lC6JCDHniPdjF1BcQPyb-FE130_provenance.